TCM
ALXN

TimesSquare Capital Management’s Alexion Pharmaceuticals ALXN Stock Holding History

TimesSquare Capital Management’s Portfolio ALXN Stock Details ALXN Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
2020
Q1 		$56.2M Buy
2017
Q2 		– Sell
2017
Q1 		$4.15M Sell
2016
Q4 		$4.26M Buy
2016
Q3 		$3.55M Sell
2016
Q2 		$3.49M Sell
2016
Q1 		$5.51M Buy
2015
Q4 		$1.42M Buy